IFNG and neoplasm: Butterfield et al. describe 3 novel epitopes (AFP542–550; AFP137–145, and AFP325–354) expressed on HLA class I for which in vitro validation demonstrates cytotoxicity and IFNγ secretion towards HLA-A*0201+/AFP+ tumour cells.